Changes in Immunophenotypes After Conversion from Calcineurin Inhibitors to mTOR Inhibitors in Renal Transplant Recipients

被引：0
|
作者：
Yildiz, A. [1 ]
Cavusoglu, M. [1 ]
Adin, S. [2 ]
Caliskan, Y. [1 ]
Ozkok, A. [1 ]
Tasci, H. [3 ]
Deniz, G. [2 ]
Sariyar, M. [3 ]
机构：
[1] Istanbul Sch Med, Internal Med, Nephrol, Istanbul, Turkey
[2] Immunol Expt Med & Res Ctr, Istanbul, Turkey
[3] Medicana Organ Transplant Ctr, Gen Surg, Istanbul, Turkey
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2015年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
1676
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Renal function in renal or liver transplant recipients after conversion from a calcineurin inhibitor to sirolimus
    Backman, L
    Reisæter, AV
    Wramner, L
    Ericzon, BG
    Salmela, K
    Brattström, C
    [J]. CLINICAL TRANSPLANTATION, 2006, 20 (03) : 336 - 339
  • [42] Long-Term Redistribution of Peripheral Lymphocyte Subpopulations after Switching from Calcineurin to mTOR Inhibitors in Kidney Transplant Recipients
    Llinas-Mallol, Laura
    Redondo-Pachon, Dolores
    Raich-Regue, Dalia
    Perez-Saez, Maria Jose
    Yelamos, Jose
    Duran, Xavier
    Faura, Anna
    Lopez-Botet, Miguel
    Pascual, Julio
    Crespo, Marta
    [J]. JOURNAL OF CLINICAL MEDICINE, 2020, 9 (04)
  • [43] THE EFFECTS OF CONVERSION FROM CNI (CALCINUERIN INHIBITORS) TO SIROLIMUS IN RENAL TRANSPLANT RECIPIENTS
    Borman, Natalie L.
    Venkat-Raman, Gopalakrishnan
    [J]. TRANSPLANT INTERNATIONAL, 2009, 22 : 115 - 115
  • [44] EFFICACY AND SAFETY OF CONVERSION FROM CALCINEURIN INHIBITORS TO SIROLIMUS VERSUS CONTINUED USE OF CALCINEURIN INHIBITORS IN RENAL ALLOGRAFT RECIPIENTS: RESULTS OF THE CONVERT TRIAL
    Pussell, B.
    Russ, G.
    Walker, R.
    Campbell, S.
    O'Connell, P.
    Kanellis, J.
    Eris, J.
    [J]. NEPHROLOGY, 2006, 11 : A35 - A35
  • [45] Steroid withdrawal in renal transplant recipients treated with m-TOR inhibitors without calcineurin inhibitors
    Franco, Antonio
    Cotilla, Eva
    Roca, Susana
    Jimenez, Luis
    Sanchez, Jose
    Olivares, Jesus
    [J]. TRANSPLANT INTERNATIONAL, 2007, 20 : 128 - 128
  • [46] Non-melanoma skin cancer outcomes in kidney transplant recipients converted from calcineurin inhibitors to mTOR inhibitors: a systematic review
    Olszewska, Berenika
    Imko-Walczuk, Beata
    Debska-Slizien, Alicja
    [J]. POSTEPY DERMATOLOGII I ALERGOLOGII, 2023, 40 (02): : 187 - 193
  • [47] Conversion From Calcineurin Inhibitors to Everolimus With Low-Dose Cyclosporine in Renal Transplant Recipients With Squamous Cell Carcinoma of the Skin
    Caroti, L.
    Zanazzi, M.
    Paudice, N.
    Tsalouchos, A.
    Carta, P.
    Larti, A.
    Pimpinelli, N.
    Moscarelli, L.
    Salvadori, M.
    Bertoni, E.
    [J]. TRANSPLANTATION PROCEEDINGS, 2012, 44 (07) : 1926 - 1927
  • [48] Conversion from calcineurin inhibitors (CNIs) to sirolimus (SRL) immunosuppression is beneficial in liver transplant (LT) recipients with renal dysfunction (RD).
    Cejas, Nora
    Casciato, Paola
    Descalzi, Valeria
    Galdame, Omar
    Gadano, Adrian
    Imventarza, Oscar
    Villamil, Federico
    [J]. LIVER TRANSPLANTATION, 2007, 13 (06) : S113 - S113
  • [49] CONVERSION FROM CALCINEURIN INHIBITORS TO EVEROLIMUS RESULTED IN DECREASE OF SERUM TGF-BETA and URINARY NGAL IN RENAL TRANSPLANT RECIPIENTS
    Alpay, Nadir
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 : 500 - 501
  • [50] THE EFFECT OF DIFFERENT CALCINEURIN INHIBITORS ON OXIDATIVE STRESS PARAMETERS IN RENAL TRANSPLANT RECIPIENTS
    Vlahovic, Predrag
    Vlahovic, Predrag
    Cvetkovic, Tatjana
    Djordjevic, Vidojko
    Velickovic-Radovanovic, Radmila
    Stefanovic, Nikola
    Ignjatovic, Aleksandra
    Sladojevic, Nikola
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 : 525 - 525
12345